{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:38:42Z","timestamp":1791970722966,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2020QNA060"],"award-info":[{"award-number":["2020QNA060"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Startup Fund for scientific research, Huaqiao University","award":["20BS113"],"award-info":[{"award-number":["20BS113"]}]},{"DOI":"10.13039\/501100018623","name":"Quanzhou City Science and Technology Program","doi-asserted-by":"publisher","award":["2022NS007"],"award-info":[{"award-number":["2022NS007"]}],"id":[{"id":"10.13039\/501100018623","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Province Natural Science Foundation","award":["2021J01309"],"award-info":[{"award-number":["2021J01309"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11030-024-10840-w","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T07:01:49Z","timestamp":1715410909000},"page":"163-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelators"],"prefix":"10.1007","volume":"29","author":[{"given":"He","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"10840_CR1","doi-asserted-by":"publisher","first-page":"778492","DOI":"10.3389\/fonc.2021.778492","volume":"11","author":"Q Guo","year":"2021","unstructured":"Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W et al (2021) The role of iron in cancer progression. Front Oncol 11:778492. https:\/\/doi.org\/10.3389\/fonc.2021.778492","journal-title":"Front Oncol"},{"key":"10840_CR2","doi-asserted-by":"publisher","first-page":"100860","DOI":"10.1016\/j.mam.2020.100860","volume":"75","author":"SV Torti","year":"2020","unstructured":"Torti SV, Torti FM (2020) Iron: the cancer connection. Mol Aspects Med 75:100860. https:\/\/doi.org\/10.1016\/j.mam.2020.100860","journal-title":"Mol Aspects Med"},{"issue":"1","key":"10840_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"SV Torti","year":"2018","unstructured":"Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM (2018) Iron and cancer. Annu Rev Nutr 38(1):97\u2013125. https:\/\/doi.org\/10.1146\/annurev-nutr-082117-051732","journal-title":"Annu Rev Nutr"},{"issue":"6","key":"10840_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acschembio.1c00122","volume":"16","author":"U Abbasi","year":"2021","unstructured":"Abbasi U, Abbina S, Gill A, Takuechi LE, Kizhakkedathu JN (2021) Role of iron in the molecular pathogenesis of diseases and therapeutic opportunities. ACS Chem Biol 16(6):945\u2013972. https:\/\/doi.org\/10.1021\/acschembio.1c00122","journal-title":"ACS Chem Biol"},{"issue":"2","key":"10840_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J et al (2022) Ferroptosis in cancer and cancer immunotherapy. Cancer Commun 42(2):88\u2013116. https:\/\/doi.org\/10.1002\/cac2.12250","journal-title":"Cancer Commun"},{"key":"10840_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fonc.2018.00549","volume":"8","author":"C Pfeifhofer-Obermair","year":"2018","unstructured":"Pfeifhofer-Obermair C, Tymoszuk P, Petzer V, Weiss G, Nairz M (2018) Iron in the tumor microenvironment\u2014connecting the dots. Front Oncol 8:549. https:\/\/doi.org\/10.3389\/fonc.2018.00549","journal-title":"Front Oncol"},{"issue":"4\u20135","key":"10840_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10534-020-00243-3","volume":"33","author":"O Ibrahim","year":"2020","unstructured":"Ibrahim O, O\u2019Sullivan J (2020) Iron chelators in cancer therapy. Biometals 33(4\u20135):201\u2013215. https:\/\/doi.org\/10.1007\/s10534-020-00243-3","journal-title":"Biometals"},{"issue":"5","key":"10840_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D (2021) Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 18(5):280\u2013296. https:\/\/doi.org\/10.1038\/s41571-020-00462-0","journal-title":"Nat Rev Clin Oncol"},{"issue":"48","key":"10840_CR9","doi-asserted-by":"publisher","first-page":"12888","DOI":"10.1039\/d0sc04082g","volume":"11","author":"EJ Anthony","year":"2020","unstructured":"Anthony EJ, Bolitho EM, Bridgewater HE, Carter OWL, Donnelly JM, Imberti C et al (2020) Metallodrugs are unique: opportunities and challenges of discovery and development. Chem Sci 11(48):12888\u201312917. https:\/\/doi.org\/10.1039\/d0sc04082g","journal-title":"Chem Sci"},{"issue":"7","key":"10840_CR10","doi-asserted-by":"publisher","first-page":"9709","DOI":"10.1007\/s13277-016-4878-4","volume":"37","author":"JL Kim","year":"2016","unstructured":"Kim JL, Lee DH, Na YJ, Kim BR, Jeong YA, Lee SI et al (2016) Iron chelator-induced apoptosis via the ER stress pathway in gastric cancer cells. Tumour Biol 37(7):9709\u20139719. https:\/\/doi.org\/10.1007\/s13277-016-4878-4","journal-title":"Tumour Biol"},{"issue":"1","key":"10840_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/s12885-016-2744-9","volume":"16","author":"H Harima","year":"2016","unstructured":"Harima H, Kaino S, Takami T, Shinoda S, Matsumoto T, Fujisawa K et al (2016) Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo. BMC Cancer 16(1):702. https:\/\/doi.org\/10.1186\/s12885-016-2744-9","journal-title":"BMC Cancer"},{"issue":"13","key":"10840_CR12","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.3390\/ijms22137168","volume":"22","author":"Y Xue","year":"2021","unstructured":"Xue Y, Zhang G, Zhou S, Wang S, Lv H, Zhou L et al (2021) Iron chelator induces apoptosis in osteosarcoma cells by disrupting intracellular iron homeostasis and activating the MAPK pathway. Int J Mol Sci 22(13):7168. https:\/\/doi.org\/10.3390\/ijms22137168","journal-title":"Int J Mol Sci"},{"key":"10840_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2018.06.012","volume":"432","author":"L Lan","year":"2018","unstructured":"Lan L, Wei W, Zheng Y, Niu L, Chen X, Huang D et al (2018) Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1\/2 mediated mitochondrial dysfunction. Cancer Lett 432:132\u2013143. https:\/\/doi.org\/10.1016\/j.canlet.2018.06.012","journal-title":"Cancer Lett"},{"issue":"3","key":"10840_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ajh.21350","volume":"84","author":"E Noulsri","year":"2009","unstructured":"Noulsri E, Richardson DR, Lerdwana S, Fucharoen S, Yamagishi T, Kalinowski DS et al (2009) Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells. Am J Hematol 84(3):170\u2013176. https:\/\/doi.org\/10.1002\/ajh.21350","journal-title":"Am J Hematol"},{"issue":"5","key":"10840_CR15","doi-asserted-by":"publisher","first-page":"165657","DOI":"10.1016\/j.bbadis.2019.165657","volume":"1866","author":"S Krishan","year":"2020","unstructured":"Krishan S, Sahni S, Leck LYW, Jansson PJ, Richardson DR (2020) Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells. Biochim Biophys Acta Mol Basis Dis 1866(5):165657. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165657","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"10840_CR16","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","volume":"104","author":"J Yuan","year":"2004","unstructured":"Yuan J, Lovejoy DB, Richardson DR (2004) Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment. Blood 104(5):1450\u20131458. https:\/\/doi.org\/10.1182\/blood-2004-03-0868","journal-title":"Blood"},{"issue":"6","key":"10840_CR17","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1021\/acs.jmedchem.8b01996","volume":"62","author":"G Chen","year":"2019","unstructured":"Chen G, Niu C, Yi J, Sun L, Cao H, Fang Y et al (2019) Novel triapine derivative induces copper-dependent cell death in hematopoietic cancers. J Med Chem 62(6):3107\u20133121. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01996","journal-title":"J Med Chem"},{"issue":"19","key":"10840_CR18","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.7150\/thno.34663","volume":"9","author":"J Zhou","year":"2019","unstructured":"Zhou J, Zhang L, Wang M, Zhou L, Feng X, Yu L et al (2019) CPX targeting DJ-1 triggers ROS-induced cell death and protective autophagy in colorectal cancer. Theranostics 9(19):5577\u20135594. https:\/\/doi.org\/10.7150\/thno.34663","journal-title":"Theranostics"},{"issue":"2","key":"10840_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/1574892816666210211090845","volume":"16","author":"Z Huang","year":"2021","unstructured":"Huang Z, Huang S (2021) Reposition of the fungicide ciclopirox for cancer treatment. Recent Pat Anti-Cancer Drug Discov 16(2):122\u2013135. https:\/\/doi.org\/10.2174\/1574892816666210211090845","journal-title":"Recent Pat Anti-Cancer Drug Discov"},{"issue":"6","key":"10840_CR20","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/cells9061529","volume":"9","author":"M Fiorillo","year":"2020","unstructured":"Fiorillo M, Toth F, Brindisi M, Sotgia F, Lisanti MP (2020) Deferiprone (DFP) targets cancer stem cell (CSC) propagation by inhibiting mitochondrial metabolism and inducing ROS production. Cells 9(6):1529. https:\/\/doi.org\/10.3390\/cells9061529","journal-title":"Cells"},{"issue":"6","key":"10840_CR21","doi-asserted-by":"publisher","first-page":"10.1002\/nbm.371","DOI":"10.1002\/nbm.3712","volume":"30","author":"RV Simoes","year":"2017","unstructured":"Simoes RV, Veeraperumal S, Serganova IS, Kruchevsky N, Varshavsky J, Blasberg RG et al (2017) Inhibition of prostate cancer proliferation by Deferiprone. NMR Biomed 30(6):10.1002\/nbm.3712. https:\/\/doi.org\/10.1002\/nbm.3712","journal-title":"NMR Biomed"},{"issue":"2b","key":"10840_CR22","first-page":"755","volume":"24","author":"E Yasumoto","year":"2004","unstructured":"Yasumoto E, Nakano K, Nakayachi T, Morshed SR, Hashimoto K, Kikuchi H et al (2004) Cytotoxic activity of deferiprone, maltol and related hydroxyketones against human tumor cell lines. Anticancer Res 24(2b):755\u2013762","journal-title":"Anticancer Res"},{"issue":"13","key":"10840_CR23","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/cancers14133225","volume":"14","author":"AW Jakobsson","year":"2022","unstructured":"Jakobsson AW, Kundu S, Guo J, Chowdhury A, Zhao M, Lindell E et al (2022) Iron chelator VLX600 inhibits mitochondrial respiration and promotes sensitization of neuroblastoma cells in nutrition-restricted conditions. Cancers (Basel) 14(13):3225. https:\/\/doi.org\/10.3390\/cancers14133225","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10840_CR24","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1158\/1535-7163.MCT-20-1099","volume":"20","author":"TL Ekstrom","year":"2021","unstructured":"Ekstrom TL, Pathoulas NM, Huehls AM, Kanakkanthara A, Karnitz LM (2021) VLX600 disrupts homologous recombination and synergizes with PARP inhibitors and cisplatin by inhibiting histone lysine demethylases. Mol Cancer Ther 20(9):1561\u20131571. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-1099","journal-title":"Mol Cancer Ther"},{"issue":"23","key":"10840_CR25","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1158\/0008-5472.CAN-19-1405","volume":"79","author":"A Kanakkanthara","year":"2019","unstructured":"Kanakkanthara A, Kurmi K, Ekstrom TL, Hou X, Purfeerst ER, Heinzen EP et al (2019) BRCA1 deficiency upregulates NNMT, which reprograms metabolism and sensitizes ovarian cancer cells to mitochondrial metabolic targeting agents. Cancer Res 79(23):5920\u20135929. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1405","journal-title":"Cancer Res"},{"issue":"1","key":"10840_CR26","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1038\/ncomms4295","volume":"5","author":"X Zhang","year":"2014","unstructured":"Zhang X, Frykn\u00e4s M, Hernlund E, Fayad W, De Milito A, Olofsson MH et al (2014) Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments. Nat Commun 5(1):3295. https:\/\/doi.org\/10.1038\/ncomms4295","journal-title":"Nat Commun"},{"issue":"4","key":"10840_CR27","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1158\/1078-0432.CCR-17-2697","volume":"24","author":"GA Vitiello","year":"2018","unstructured":"Vitiello GA, Medina BD, Zeng S, Bowler TG, Zhang JQ, Loo JK et al (2018) Mitochondrial inhibition augments the efficacy of imatinib by resetting the metabolic phenotype of gastrointestinal stromal tumor. Clin Cancer Res 24(4):972\u2013984. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2697","journal-title":"Clin Cancer Res"},{"key":"10840_CR28","doi-asserted-by":"publisher","first-page":"38343","DOI":"10.1038\/srep38343","volume":"6","author":"M Fryknas","year":"2016","unstructured":"Fryknas M, Zhang X, Bremberg U, Senkowski W, Olofsson MH, Brandt P et al (2016) Iron chelators target both proliferating and quiescent cancer cells. Sci Rep 6:38343. https:\/\/doi.org\/10.1038\/srep38343","journal-title":"Sci Rep"},{"issue":"4","key":"10840_CR29","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s10637-018-0703-9","volume":"37","author":"K Mody","year":"2019","unstructured":"Mody K, Mansfield AS, Vemireddy L, Nygren P, Gulbo J, Borad M (2019) A phase I study of the safety and tolerability of VLX600, an iron chelator, in patients with refractory advanced solid tumors. Invest New Drugs 37(4):684\u2013692. https:\/\/doi.org\/10.1007\/s10637-018-0703-9","journal-title":"Invest New Drugs"},{"issue":"3","key":"10840_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1021\/acs.jmedchem.7b01319","volume":"61","author":"W Zhang","year":"2018","unstructured":"Zhang W, Lun S, Wang S-H, Jiang X-W, Yang F, Tang J et al (2018) Identification of novel coumestan derivatives as polyketide synthase 13 inhibitors against Mycobacterium tuberculosis. J Med Chem 61(3):791\u2013803. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01319","journal-title":"J Med Chem"},{"issue":"22","key":"10840_CR31","doi-asserted-by":"publisher","first-page":"16626","DOI":"10.1021\/acs.jmedchem.1c01219","volume":"64","author":"Y Dong","year":"2021","unstructured":"Dong Y, Fu R, Chen J, Zhang K, Ji M, Wang M et al (2021) Discovery of benzocyclic sulfone derivatives as potent CXCR2 antagonists for cancer immunotherapy. J Med Chem 64(22):16626\u201316640. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01219","journal-title":"J Med Chem"},{"key":"10840_CR32","doi-asserted-by":"publisher","first-page":"115023","DOI":"10.1016\/j.ejmech.2022.115023","volume":"247","author":"C Chen","year":"2023","unstructured":"Chen C, Lu T, Chen P, Li Z, Yang Y, Fan S et al (2023) Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injury. Eur J Med Chem 247:115023. https:\/\/doi.org\/10.1016\/j.ejmech.2022.115023","journal-title":"Eur J Med Chem"},{"key":"10840_CR33","doi-asserted-by":"publisher","first-page":"113998","DOI":"10.1016\/j.ejmech.2021.113998","volume":"229","author":"Y Wang","year":"2022","unstructured":"Wang Y, Kun H, Gao Y, Yuan D, Ling L, Liu J et al (2022) Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1\/programmed cell death-ligand 1 (PD-1\/PD-L1) interaction. Eur J Med Chem 229:113998. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113998","journal-title":"Eur J Med Chem"},{"key":"10840_CR34","doi-asserted-by":"publisher","first-page":"645593","DOI":"10.3389\/fcell.2021.645593","volume":"9","author":"R Kumari","year":"2021","unstructured":"Kumari R, Jat P (2021) Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol 9:645593. https:\/\/doi.org\/10.3389\/fcell.2021.645593","journal-title":"Front Cell Dev Biol"},{"issue":"25","key":"10840_CR35","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/jco.2016.69.0032","volume":"35","author":"M Ingham","year":"2017","unstructured":"Ingham M, Schwartz GK (2017) Cell-cycle therapeutics come of age. J Clin Oncol 35(25):2949\u20132959. https:\/\/doi.org\/10.1200\/jco.2016.69.0032","journal-title":"J Clin Oncol"},{"issue":"4","key":"10840_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1039\/c0ib00144a","volume":"3","author":"J Plati","year":"2011","unstructured":"Plati J, Bucur O, Khosravi-Far R (2011) Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) 3(4):279\u2013296. https:\/\/doi.org\/10.1039\/c0ib00144a","journal-title":"Integr Biol (Camb)"},{"issue":"12","key":"10840_CR37","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2017.10.006","volume":"3","author":"PJ Burke","year":"2017","unstructured":"Burke PJ (2017) Mitochondria, bioenergetics and apoptosis in cancer. Trends Cancer 3(12):857\u2013870. https:\/\/doi.org\/10.1016\/j.trecan.2017.10.006","journal-title":"Trends Cancer"},{"issue":"7","key":"10840_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17(7):395\u2013417. https:\/\/doi.org\/10.1038\/s41571-020-0341-y","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10840_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/onc.2011.228","volume":"31","author":"GS Coombs","year":"2012","unstructured":"Coombs GS, Schmitt AA, Canning CA, Alok A, Low IC, Banerjee N et al (2012) Modulation of Wnt\/beta-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer. Oncogene 31(2):213\u2013225. https:\/\/doi.org\/10.1038\/onc.2011.228","journal-title":"Oncogene"},{"key":"10840_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321","volume":"14","author":"Z Su","year":"2015","unstructured":"Su Z, Yang Z, Xu Y, Chen Y, Yu Q (2015) Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 14:48. https:\/\/doi.org\/10.1186\/s12943-015-0321","journal-title":"Mol Cancer"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10840-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10840-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10840-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T16:39:38Z","timestamp":1738341578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10840-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10840"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10840-w","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"15 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}